http://www.anaptysbio.com
AnaptysBio, Inc. Company Intro
AnaptysBio is a clinical-stage antibody development company advancing therapeutic antibody product candidates focused on unmet medical needs in inflammation.
Industry
Healthcare
AnaptysBio, Inc. Headquaters
10421 Pacific Center Court
San Diego,92121
United States
AnaptysBio, Inc. Share price
14 Sep 2022 08:36 GMT
$23.65
-2.13 (-8.26 %)
AnaptysBio, Inc. Market cap
$667.575 M
WMC RANKING
2022
AnaptysBio, Inc. # 87
BiotechnologyLatest AnaptysBio, Inc. News
09 Dec 2022
UCB Aims High In Hidradenitis Suppurativa After Bimzelx ...
... with antibiotics and AbbVie Inc.'s tumor necrosis factor-alpha inhibitor ... a failure with AnaptysBio, Inc. discontinuing studies in the indication of...
09 Dec 2022
UCB Aims High In Hidradenitis Suppurativa After Bimzelx ...
UCB Aims High In Hidradenitis Suppurativa After Bimzelx ...
08 Dec 2022
Epidermal Growth Factor Receptor (EGFR) Inhibitors-Induced ...
The major key players, including Lutris Pharma Ltd., and Hoth Therapeutics, among others, hold the potential to ... Imsidolimab (ANB019): AnaptysBio Inc.
WMC Market Score
WMC Market to Revenue Score
AnaptysBio, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| AnaptysBio, Inc. | USD | $71,247 | $103,234 | $-29,832 | $6,676M | 87 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $754,300B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $713,610B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $150,520B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total AnaptysBio, Inc. Social Followers vs Top 4 Industry Competitors
AnaptysBio, Inc. Post vs Top 4 Industry Competitors
AnaptysBio, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
AnaptysBio, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
AnaptysBio, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| AnaptysBio, Inc. | 0.77 | 2.51 | 0.01 | 0 | 0 | 0 | 1.13 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 22 | 0 | 0 | 28.52 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 33 | 0 | 0 | 34.78 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 22 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 47.37 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
